Indoco Remedies Limited (NSE:INDOCO)
218.92
-8.99 (-3.94%)
May 11, 2026, 3:29 PM IST
Indoco Remedies Revenue
In the fiscal year ending March 31, 2026, Indoco Remedies had annual revenue of 18.49B INR with 11.04% growth. Indoco Remedies had revenue of 4.76B in the quarter ending March 31, 2026, with 21.88% growth.
Revenue
18.49B
Revenue Growth
+11.04%
P/S Ratio
1.09
Revenue / Employee
3.08M
Employees
6,000
Market Cap
20.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.49B | 1.84B | 11.04% |
| Mar 31, 2025 | 16.65B | -1.52B | -8.38% |
| Mar 31, 2024 | 18.17B | 1.49B | 8.91% |
| Mar 31, 2023 | 16.69B | 1.28B | 8.30% |
| Mar 31, 2022 | 15.41B | 2.99B | 24.10% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innova Captab | 16.37B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.85B |
Indoco Remedies News
- 3 days ago - Pharma sector stocks today, May 8: Indoco Remedies falls 6%, Natco Pharma jumps 2.57%, Mankind Pharma up 2.43% - Business Upturn
- 4 days ago - Indoco Remedies Transcript: Q4 25/26 - Transcripts
- 13 days ago - Pharma sector stocks today, April 28: Glenmark Pharma surge 1.80%, Strides Pharma down 2%, Indoco Remedies up 1.52% - Business Upturn
- 26 days ago - Pharma sector stocks surge today, April 15: Indoco Remedies up 5%, Orchid Pharma gains 4.04%, Dr. Reddy's falls 1.64% - Business Upturn
- 2 months ago - Indoco Remedies receives USFDA final approval for Brivaracetam Oral Solution 10 mg/mL - Business Upturn
- 3 months ago - Q3 2026 Indoco Remedies Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Indoco Remedies Transcript: Q3 25/26 - Transcripts
- 3 months ago - Indoco Remedies Q3 Results: Revenue rises 8.5% YoY to Rs 445.4 crore, net loss at Rs 29.8 crore - Business Upturn